Table 3 Therapy regime depending on the number of patients treated per year
From: ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
Number of patients treated per year | |||||||
|---|---|---|---|---|---|---|---|
0–5 | 6–10 | > 10 | |||||
n | % | n | % | n | % | ||
Distribution | 116 | 58 | 54 | 27 | 29 | 15 | |
Platelet count/μl | 8444 ± 9115 | 13926 ± 15410 | 6776 ± 12310 | ||||
Intensive care unit | No | 36 | 31.3% | 0 | 0.0% | 0 | 0.0% |
Yes | 79 | 68.7% | 54 | 100% | 29 | 100% | |
Hematological outpatient clinic | No | 94 | 81.0% | 34 | 62.9% | 3 | 10.3% |
Yes | 22 | 18.9% | 20 | 37.0% | 26 | 89.7% | |
Therapy | No | 50 | 43.1% | 25 | 46.3% | 9 | 31.0% |
Yes | 66 | 56.9% | 29 | 53.7% | 20 | 68.9% | |
Therapy modality | None | 50 | 43.1% | 25 | 46.3% | 9 | 31.0% |
IVIG | 27 | 23.3% | 18 | 33.3% | 13 | 44.8% | |
GC | 22 | 18.9% | 6 | 11.1% | 2 | 6.9% | |
IGIV and GC | 10 | 8.6% | 2 | 3.7% | 4 | 13.8% | |
Blood products alone | 0 | 0.0% | 0 | 0.0% | 1 | 3.5% | |
Blood products, IVIG + GC | 7 | 6.0% | 3 | 5.56% | 0 | 0.0% | |